All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997–2010
Authors:
- Victoria HernandoVHVictoria Hernando
- CoRIS cohortCCCoRIS cohort
- Belen AlejosBABelen Alejos
- Susana MongeSMSusana Monge
- Juan BerenguerJBJuan Berenguer
- Lourdes AntaLALourdes Anta
- David VinuesaDVDavid Vinuesa
- Rosario PalaciosRPRosario Palacios
- Roberto MugaRMRoberto Muga
- Santiago MorenoSMSantiago Moreno
- Inma JarrinIJInma Jarrin
Open Access
- 20 August 2013
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 13 (1) , 382
Abstract
Combination antiretroviral therapy (cART) has produced significant changes in mortality of HIV-infected persons. Our objective was to estimate mortality rates, standardized mortality ratios and excess mortality rates of cohorts of the AIDS Research Network (RIS) (CoRIS-MD and CoRIS) compared to the general population. We analysed data of CoRIS-MD and CoRIS cohorts from 1997 to 2010. We calculated: (i) all-cause mortality rates, (ii) standardized mortality ratio (SMR) and (iii) excess mortality rates for both cohort for 100 person-years (py) of follow-up, comparing all-cause mortality with that of the general population of similar age and gender. Between 1997 and 2010, 8,214 HIV positive subjects were included, 2,453 (29.9%) in CoRIS-MD and 5,761 (70.1%) in CoRIS and 294 deaths were registered. All-cause mortality rate was 1.02 (95% CI 0.91-1.15) per 100 py, SMR was 6.8 (95% CI 5.9-7.9) and excess mortality rate was 0.8 (95% CI 0.7-0.9) per 100 py. Mortality was higher in patients with AIDS, hepatitis C virus (HCV) co-infection, and those from CoRIS-MD cohort (1997–2003). Mortality among HIV-positive persons remains higher than that of the general population of similar age and sex, with significant differences depending on the history of AIDS or HCV coinfection.Keywords
This publication has 23 references indexed in Scilit:
- All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infectionJournal of Hepatology, 2012
- All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaborationInternational Journal of Epidemiology, 2011
- Mortality by causes in HIV-infected adults: comparison with the general populationBMC Public Health, 2011
- Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort StudiesClinical Infectious Diseases, 2010
- The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individualsAIDS, 2010
- Meta‐Analysis: Increased Mortality Associated with Hepatitis C in HIV‐Infected Persons Is Unrelated to HIV Disease ProgressionClinical Infectious Diseases, 2009
- Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countriesInternational Journal of Epidemiology, 2009
- Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV‐Infected Patients in Spain, 1997–2006Clinical Infectious Diseases, 2009
- Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): metodología y primeros resultadosEnfermedades Infecciosas y Microbiología Clínica, 2007
- Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter CohortPLOS ONE, 2006